文献速递胸部肿瘤

早期肺癌治疗研究计划:研究设计开发与试点实施

Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation.
PubMed 文献 · J Thorac Oncol · 2018-03-23

为优化早期小肺癌的治疗,研究者通过患者与医生焦点小组、文献回顾及大型数据库分析,设计了前瞻性多中心队列研究(IELCART),比较I期NSCLC不同治疗方式。试点纳入前206例手术患者,肺叶切除89例(43.2%),亚肺叶切除117例(56.7%);纵隔淋巴结清扫173例(84.0%),其中8例N1、3例N2转移。患者认为外科医生意见(93%)和自身意见(93%)极其重要,其次为所选术式能提供最佳生活质量(90%)。预计3至5年内获得有统计学意义的治疗比较结果。

要点

  • IELCART为前瞻性多中心队列,比较I期NSCLC不同治疗方式的长期结局。
  • 试点206例手术患者中,亚肺叶切除占56.7%,肺叶切除占43.2%。
  • 患者重视医生意见与自身意见(均93%),以及最佳生活质量(90%)。

核心结论

  • 从患者和外科医生处获取术前与术后信息是可行的。
  • 预计3至5年内可获得关于替代治疗的有统计学意义的结果。

研究设计与样本

  • 通过患者与医生分别进行的焦点小组会议、文献回顾及大型数据库治疗结果分析,形成关于长期结局、复发和生活质量的关键问题。
  • 据此设计前瞻性多中心队列研究IELCART,比较I期NSCLC的治疗。
  • 获得HIPAA合规的机构审查委员会批准后,对前206例手术患者进行可行性研究。

主要发现

  • 206例手术患者中,肺叶切除89例(43.2%),亚肺叶切除117例(56.7%)。
  • 纵隔淋巴结切除173例(84.0%),其中8例N1、3例N2淋巴结转移。
  • 患者表示外科医生意见(93%)和患者自身意见(93%)极其重要,其次为所选术式能提供最佳生活质量(90%)。

临床怎么用

  • 在早期肺癌治疗决策中应同时重视外科医生意见与患者自身意见。
  • 应将所选术式对生活质量的影响纳入治疗选择考量。

局限性

  • 试点可行性研究仅纳入前206例手术患者,尚不能提供治疗方式的比较疗效结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: To maximize the benefits of computed tomographic screening for lung cancer, optimal treatment for small, early lung cancers is needed. Limiting the extent of surgery spares lung tissue, preserves pulmonary function, and decreases operative time, complications, and morbidities. It also increases the likelihood of resecting future new primary lung cancers. The goal is to assess alternative treatments in a timely manner. METHODS: The focus sessions with patients and physicians separately highlighted the need to consider their perceptions. Literature reviews and analyses of treatment results using large databases were performed to formulate critical questions about long-term treatment outcomes, recurrence, and quality of life of alternative treatments. Based on these analyses, the investigators developed a prospective multi-institutional cohort study, the Initiative for Early Lung Cancer Research for Treatment, to compare treatments for stage I NSCLC. HIPAA compliant institutional review board approval was obtained and we performed a feasibility study of the first 206 surgical patients. RESULTS: Lobectomy was performed in 89 (43.2%) patients, and sublobar resection was performed in 117 (56.7%) patients. Mediastinal lymph node resection was performed in 173 (84.0%) patients, 8 had N1 and 3 N2 lymph node metastases. Patients stated that both the surgeon's opinion (93%) and the patient's own opinion (93%) were extremely important, followed by the patients' view that the chosen procedure would provide the best quality of life (90%). CONCLUSIONS: It was feasible to obtain pre- and postsurgical information from patients and surgeons. We anticipate statistically meaningful results about treatment alternatives in 3 to 5 years.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Flores R, Taioli E, Yankelevitz DF, et al. Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation. J Thorac Oncol. 2018. PMID: 29578108. doi:10.1016/j.jtho.2018.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。